SYDNEY, Sept. 26, 2024 /PRNewswire/ — Aiper, the global creator of innovative, cordless robotic pool cleaners, officially launched its next generation of cordless pool cleaning robots – the Scuba Series – at a lavish celebration event in Sydney last night. Held at a breathtaking private mansion in Darling Point, the launch was attended by over 100 […]
Category Archives: Pr Newswire
SYDNEY, Sept. 26, 2024 /PRNewswire/ — Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewed study validating its innovative method for measuring central aortic pressure—an important indicator of heart health—using a noninvasive fingertip sensor. The study, co-authored by Cardiex’s team, was […]
MELBOURNE, Australia, Sept. 26, 2024 /PRNewswire/ — Firmable, the Australian tech start-up known for its deep local B2B data, has launched its Australian Construction Database – the first comprehensive mapping and standardisation of data in one of Australia’s largest industries. This product opens new opportunities for businesses targeting the construction industry, by providing accurate, up-to-date insights […]
The WEKA Data Platform is Now Certified as a High-Performance Data Store Solution with the NVIDIA Cloud Partner Reference Architecture for GPU Compute Infrastructure CAMPBELL, Calif., Sept. 26, 2024 /PRNewswire/ — WekaIO (WEKA), the AI-native data platform company, today announced that the WEKA® Data Platform has been certified as a high-performance data store for NVIDIA […]
SINGAPORE, Sept. 26, 2024 /PRNewswire/ — Caravelle International Group (Nasdaq: CACO), a global ocean technology company, today announced that its ordinary shares will begin trading on NASDAQ under the ticker symbol ‘HTCO’ prior to market open on September 30, 2024. This will replace the company’s current ticker symbol ‘CACO’, which has been used since its […]
Pr Newswire
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
25
Sep
Sep
Rostock International Parkinson’s Disease (ROPAD) Study demonstrates a significant link between the RAB32 gene variant and Parkinson’s disease, further supporting recent findings Data from over subcohort of 3,350 patients shows that the RAB32 mutation is over 100 times more prevalent in Parkinson’s patients than in the general population CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, […]
Pr Newswire
3Daughters Announces NIH to Support Testing of Novel Frameless Magnetic Copper IUD (3D-001) for Contraception
25
Sep
Sep
NICHD to Support Evaluation of Copper Release Characteristics of 3D-001in a Preclinical Model, as Company Prepares for Phase 1 Clinical Trial MANSFIELD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) — 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, announced the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at […]
Pr Newswire
Haywood Street Community Development’s Nourish & Nest Brings Million Dollar Fundraising Goal Within Reach
25
Sep
Sep
North Carolina Executives, James Beard Award Winning Chefs, Restaurants & Retailers Vital to Effort to Complete Much Needed Housing ASHEVILLE, N.C., Sept. 25, 2024 (GLOBE NEWSWIRE) — Haywood Street Community Development is closer to its $1 million fundraising goal this year following its Nourish & Nest fundraiser at Chai Pani. The evening’s sponsors included Aeroflow […]
Pr Newswire
Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference
25
Sep
Sep
SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced two presentations at OPTIONS XII for the Control of Influenza conference, to […]
Pr Newswire
Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension
25
Sep
Sep
– On track to announce topline data in Q1 2025 – – Virtual KOL event scheduled on October 30th to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program for lorundrostat in hypertension – RADNOR, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), […]